Trust Point’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Trust Point's BIIB Position: Q3 2026 in Review
Trust Point increased its Biogen (BIIB) stake by 49% in Q3 2026, buying an estimated $112K and bringing the position to 1,605 shares worth $363K. The position accounts for 0.03% of the portfolio, ranked #327.
Trust Point first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Trust Point held 1,605 shares of Biogen worth $363K as of Q3 2026.
- Trust Point bought 527 Biogen shares in Q3 2026, an estimated $112K.
- Biogen made up 0.03% of Trust Point's portfolio in Q3 2026, its #327 holding.
- Trust Point first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.